p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy

M Mingming Cao (Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University) Y Yu Gan (Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine) Y Yingdan Huang (Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University) J Jing Tong (Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University) C Chen Xiong (Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University) Y Yajie Chen (Department of Oncology, Shanghai Medical College, Fudan University) B Bing Chen R Ruixuan Huang (Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University) B Bangxiang Xie (Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University) J Jun Deng (Center for High Pressure Science and Technology Advanced Research) S Shenglin Huang (Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University) X Xianghuo He (Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University) Q Qian Hao (Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University) X Xiang Zhou

Abstract

The tumor suppressor p53 can trigger tumor resistance to chemotherapy by facilitating DNA damage repair and maintaining genomic integrity. Here, we report that a p53-induced circular RNA circASCC3 promotes chemotherapeutic resistance by resolving R-loops. Our results reveal that p53 directly activates the transcription of ASCC3 , the host gene of circASCC3. In addition, the RNA-binding protein SFPQ is identified to inhibit the formation of circASCC3 by associating with its flanking regions. Importantly, p53 facilitates the formation of circASCC3 by repressing the expression of SFPQ. CircASCC3 has a marginal effect on the survival and growth of cancer cells under normal growing conditions but surprisingly boosts their survival and growth in response to DNA damage stress. Mechanistic analysis reveals that circASCC3 binds to the DEAD-box RNA helicase DDX5 to inhibit its proteasomal degradation. This results in the prevention of R-loop accumulation due to DNA damage, thereby conferring tumor resistance to chemotherapy. Together, our study uncovers that p53 activates circASCC3 to promote R-loop resolution, which maintains genomic stability and potentially contributes to chemoresistance.

Article Details

Volume / Issue Vol. 122, Issue 11
Published March 18, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (14)

M

Mingming Cao

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University

Y

Yu Gan

Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine

Y

Yingdan Huang

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University

J

Jing Tong

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University

C

Chen Xiong

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University

Y

Yajie Chen

Department of Oncology, Shanghai Medical College, Fudan University

B

Bing Chen

R

Ruixuan Huang

Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University

B

Bangxiang Xie

Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University

J

Jun Deng

Center for High Pressure Science and Technology Advanced Research

S

Shenglin Huang

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University

X

Xianghuo He

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University

Q

Qian Hao

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University

X

Xiang Zhou